Nanobiotix - ADR Forecast, price target & analysts
Nanobiotix - ADR Target price 2025 - Analyst rating & recommendation
Nanobiotix - ADR Classifications & Recommendation:
Nanobiotix - ADR Price Target
| Target Price | $24.31 |
| Price | $20.80 |
| Potential |
16.86%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Nanobiotix - ADR 2026 .
The average Nanobiotix - ADR target price is $24.31.
This is
16.86%
register free of charge
$32.96
58.44%
register free of charge
$11.74
43.55%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Nanobiotix - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Nanobiotix - ADR stock has an average upside potential 2026 of
16.86%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | -13.49 | 41.12 |
| 138.61% | 404.80% | |
| EBITDA Margin | 575.39% | -125.01% |
| 789.20% | 121.73% | |
| Net Margin | 587.10% | -87.59% |
| 544.49% | 114.92% |
7 Analysts have issued a sales forecast Nanobiotix - ADR 2025 . The average Nanobiotix - ADR sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Nanobiotix - ADR EBITDA forecast 2025. The average Nanobiotix - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Nanobiotix - ADR Analysts have issued a net profit forecast 2025. The average Nanobiotix - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.68 | -0.75 |
| 34.40% | 55.36% | |
| P/E | negative | |
| EV/Sales | 24.66 |
7 Analysts have issued a Nanobiotix - ADR forecast for earnings per share. The average Nanobiotix - ADR EPS is
This results in the following potential growth metrics and future valuations:
Nanobiotix - ADR...
Current Nanobiotix - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Aug 05 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 09 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 08 2025 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | May 27 2025 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | May 26 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | May 22 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | May 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Aug 05 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 09 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 08 2025 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
May 27 2025 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
May 26 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
May 22 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
May 21 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
